Research data show that weight regain after discontinuation of GLP-1 or GLP-1/GIP agonists is a significant risk.
Madison Holmes, PharmD, BCPS
Advertisement
Articles by Madison Holmes, PharmD, BCPS
Stiff Person Syndrome has unique complexities, necessitating the role of pharmacists in managing its symptoms and treatment options.
Pharmacists play an important role in managing patients with this complex condition.
Advertisement
Latest Updated Articles
How Pharmacy Students Can Master Interview Skills, According to ExpertsPublished: September 29th 2025 | Updated:
Are the Weight Loss Effects of Tirzepatide and Semaglutide Temporary?Published: January 29th 2026 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
Enlicitide Meaningfully Lowers LDL-C at 24 Weeks in Patients At Risk for ASCVD Events
3
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
4
Balancing Survival and Quality of Life in Pancreatic Cancer: Expert Perspectives From an Immuneering Panel
5